Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-14
Closed -$1.38K 1079
2025
Q2
$1.38K Hold
14
﹤0.01% 917
2025
Q1
$1.3K Hold
14
﹤0.01% 886
2024
Q4
$1.27K Buy
+14
New +$1.29K ﹤0.01% 931
2024
Q3
Sell
-12
Closed -$1.18K 1218
2024
Q2
$1.18K Buy
12
+5
+71% +$464 ﹤0.01% 1006
2024
Q1
$666 Hold
7
﹤0.01% 1011
2023
Q4
$666 Buy
+7
New +$654 ﹤0.01% 1011

Other funds holding AMED

Sachetta's AMED Position: Q3 2025 in Review

Sachetta sold out of Amedisys (AMED) in Q3 2025, closing a stake of 14 shares — an estimated $1.38K sold.

Sachetta first reported a position in AMED in Q4 2023 and held it in 6 quarters. The position peaked at $1.38K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Sachetta reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Sachetta sold 14 Amedisys shares in Q3 2025, an estimated $1.38K.
  • Sachetta first reported a position in Amedisys in Q4 2023 and held it in 6 quarters.
  • Sachetta's Amedisys position peaked at $1.38K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Sachetta's 13F filing for Q3 2025, filed 24 Oct 2025.